Kári Stefánsson
From Wikipedia, the free encyclopedia
Dr. Kári Stefánsson, M.D., Dr.Med. from the University of Iceland, is the Chairman, CEO and co-founder of deCODE Genetics and a former professor of neurology, neuropathology and neuroscience at Harvard University (1993-1997). From 1993-1996 he was director of neuropathology at Boston's Beth Israel Hospital. Dr. Stefánsson also held faculty positions at the University of Chicago.
Dr. Stefánsson opened the NASDAQ Stock Market on July 20, 2005, after deCode's five year anniversary on the NASDAQ Market.
 |
This Icelandic biographical article is a stub. You can help Wikipedia by expanding it. |
